Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 3, 2008

BioTime Inks Letter of Intent with International Stem Cell

  • BioTime and its wholly owned subsidiary, Embryome Sciences, signed a letter of intent with International Stem Cell and its wholly- wned subsidiary, Lifeline Cell Technology, to jointly produce and distribute a wide array of research products from human embryonic stem cell technology.

    Under the collaborative production and manufacturing agreement, the parties intend to manufacture ESpy™ cell lines (complex derivatives of hES cells that send beacons of light in response to the activation of particular genes) as well as a host of supplies scientists will utilize in the field of stem cell research.

    The progenitor cell lines will be produced and distributed in joint efforts utilizing Embryome Science’s Embryomics™ technology, its future embryome.com online database, and technology and approved hES cell lines licensed from the Wisconsin Alumni Research Foundation. Lifeline will contribute its manufacturing and quality control expertise.